logo
AAT Bioquest

Buccutite™ Rapid Crosslinked APC Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*

Flow cytometry analysis of CD4 PBMC populations. Anti-human CD4 monoclonal antibody was labeled using Buccutite™ Rapid Crosslinked APC Antibody Labeling Kit *Production Scale* (Cat No. 5406) or Lightning-Link® Rapid APC Antibody Labeling Kit according to manufacturers’ instructions. CD4 PBMC populations were then stained, and the fluorescence signal was monitored using an ACEA NovoCyte flow cytometer in the APC channel.
Flow cytometry analysis of CD4 PBMC populations. Anti-human CD4 monoclonal antibody was labeled using Buccutite™ Rapid Crosslinked APC Antibody Labeling Kit *Production Scale* (Cat No. 5406) or Lightning-Link® Rapid APC Antibody Labeling Kit according to manufacturers’ instructions. CD4 PBMC populations were then stained, and the fluorescence signal was monitored using an ACEA NovoCyte flow cytometer in the APC channel.
Flow cytometry analysis of CD4 PBMC populations. Anti-human CD4 monoclonal antibody was labeled using Buccutite™ Rapid Crosslinked APC Antibody Labeling Kit *Production Scale* (Cat No. 5406) or Lightning-Link® Rapid APC Antibody Labeling Kit according to manufacturers’ instructions. CD4 PBMC populations were then stained, and the fluorescence signal was monitored using an ACEA NovoCyte flow cytometer in the APC channel.
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Spectral properties
Correction Factor (280 nm)0.195
Extinction coefficient (cm -1 M -1)730000
Excitation (nm)651
Emission (nm)660
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
UNSPSC12171501
Related products
Buccutite™ Rapid PE Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid APC Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Peroxidase (HRP) Antibody Conjugation Kit *Optimized for Labeling 100 ug Protein*
Buccutite™ Rapid Protein Crosslinking Kit *Microscale Optimized for Crosslinking 100 ug Antibody Per Reaction*
Buccutite™ Rapid PE Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid APC Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Cy5.5 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Cy7 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Texas Red Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Cy5 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid APC-Cy5.5 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid APC-iFluor® 700 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid APC-Cy7 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid PerCP Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Cy5 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Cy5.5 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Cy7 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid PE-Texas Red Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid APC-iFluor® 700 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid APC-Cy5.5 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid APC-Cy7 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid PerCP Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Peroxidase (HRP) Antibody Conjugation Kit *Optimized for Labeling 25 ug Protein*
Buccutite™ Peroxidase (HRP) Antibody Conjugation Kit *Optimized for Labeling 1 mg Protein*
Buccutite™ MTA, NHS ester
Buccutite™ FOL scavenger
Buccutite™ MTA scavenger
Buccutite™ MTA-Dye 650
Buccutite™ FOL-Dye 650
Buccutite™ ALP (Alkaline Phosphatase) Antibody Conjugation Kit *Optimized for Labeling 25 ug Protein*
Buccutite™ ALP (Alkaline Phosphatase) Antibody Conjugation Kit *Optimized for Labeling 100 ug Protein*
Buccutite™ ALP (Alkaline Phosphatase) Antibody Conjugation Kit *Optimized for Labeling 1 mg Protein*
Buccutite™ Poly-HRP Antibody Conjugation Kit
Buccutite™ FOL, maleimide [FOLM]
Buccutite™ MTA, maleimide [MTAM]
Buccutite™ FOL, NHS ester
Buccutite™ Rapid APC-iFluor® 750 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 25 ug Antibody Per Reaction*
Buccutite™ Rapid trFluor™ D2 Acceptor Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Buccutite™ Streptavidin Antibody Conjugation Kit *Optimized for Labeling 25 ug Protein*
Buccutite™ Streptavidin Antibody Conjugation Kit *Optimized for Labeling 100 ug Protein*
Buccutite™ Streptavidin Antibody Conjugation Kit *Optimized for Labeling 1 mg Protein*
Buccutite™ Rapid Oligo Antibody Conjugation Kit *Optimized for Labeling 100 ug Protein*
Buccutite™ Rapid PE Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid PerCP Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid PE-Cy7 Tandem Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid PE-Texas Red Tandem Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid PE-Cy5 Tandem Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid APC-iFluor® 700 Tandem Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid APC-Cy5.5 Tandem Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Buccutite™ Rapid APC-Cy7 Tandem Antibody Labeling Kit *Production Scale Optimized for Labeling 1 mg Antibody Per Reaction*
Show More (40)

OverviewpdfSDSpdfProtocol


Correction Factor (280 nm)
0.195
Extinction coefficient (cm -1 M -1)
730000
Excitation (nm)
651
Emission (nm)
660
Buccutite™ Rapid Crosslinked APC Antibody Labeling Kits, designed for large-scale production, offer a convenient and efficient method to label antibodies with APC, PE, and iFluor® tandem dyes. In comparison to traditional protein-protein conjugation methods like the SMCC crosslinking technique, Buccutite™ conjugation is simple and more robust. Using a two-step mixing protocol, researchers can directly conjugate APC to any antibody or protein in less than 2 hours. Each Buccutite™ kit includes all the essential components for two labeling reactions and features a user-friendly, pre-packed spin column to maximize conjugate yield. Each Buccutite™ FOL-Activated APC vial provided in this kit is precisely formulated to label 1 mg of purified protein or antibody. Before labeling, it's important to remove stabilizing proteins like BSA from the sample and avoid using amine-rich buffers like Tris, which might disrupt the labeling process. Allophycocyanin (APC) is an intensely bright, red fluorescent phycobiliprotein with an excitation and emission maxima of ~651 nm and ~660 nm, respectively. Given its intense brightness, APC is recommended for pairing with low-abundance targets to minimize spillover and compensation. APC conjugates are well-suited for FRET screening, flow cytometry, spectral flow cytometry, and other immunoassays requiring high sensitivity but not photostability. With Buccuitte™ Rapid Antibody Labeling kits, researchers can directly label primary antibodies, eliminating the need for secondary antibodies and enhancing panel-building flexibility.

Components


Example protocol


AT A GLANCE

Key Parameters to Achieve Best Performance
  1. 1.0 mg Antibody (MW ~150 kDa)

  2. Antibody concentration: 2.0 mg/mL

  3. Antibody volume: 500 µL

PREPARATION OF WORKING SOLUTION

Important

Before opening the vials, warm all components and briefly centrifuge. Immediately prepare necessary solutions before starting conjugation. This protocol is a recommendation.

Prepare Antibody Solution
  1. Prepare a 500 µL antibody solution in PBS with a concentration of 2 mg/mL.

    Note: The protein should be dissolved in 1X phosphate-buffered saline (PBS), pH 7.2 - 7.4. If the protein is dissolved in buffers containing primary amines, like Tris and/or glycine, it must be dialyzed against 1X PBS, pH 7.2 - 7.4, or use Amicon Ultra0.5, Ultracel-10 Membrane, 10 kDa (Cat No. UFC501008 from Millipore) to remove free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) that are widely used for protein precipitation.

    Note: Impure antibodies or antibodies stabilized with bovine serum albumin (BSA) or gelatin will not be labeled well.

Prepare Buccutite™ MTA Solution
  1. Allow a vial of Buccutite™ MTA (Component B) to warm to room temperature.

  2. Add 5 µL of DMSO (not provided) to the vial of Buccutite™ MTA (Component B), and mix well by pipetting.

SAMPLE EXPERIMENTAL PROTOCOL

Run Antibody-Buccutite™ MTA Reaction
  1. Add 25 µL of Reaction Buffer (Component C) to the antibody solution.

  2. Transfer 5 µL of the reconstituted Buccutite™ MTA DMSO solution into the vial of antibody solution, and mix well by pipetting.

  3. Rotate the reaction mixture at room temperature for 1 hour, then purify using a desalting column.

Purify Antibody-Buccutite™ MTA Solution with Desalting Column
  1. Invert the provided spin column (Component D) several times to re-suspend the settled gel and remove any bubbles.

  2. Snap off the tip and place the column in a washing tube (2 mL, not provided). Remove the cap to allow the excess packing buffer to drain by gravity to the top of the gel bed.

    Note: If the column does not begin to flow, push the cap back into the column and remove it again to start the flow. Discard the drained buffer, and then place the column back into the Washing Tube. 

  3. Centrifuge at 1000 x g for 2 minutes in a swinging bucket centrifuge to remove the packing buffer. Then discard the buffer. Refer to the 'Centrifugation Notes' section below for instructions.

  4. Apply 1-2 mL 1X PBS (pH 7.2-7.4) to the column. After each application of PBS, let the buffer drain out by gravity, or centrifuge the column for 2 minutes to remove the buffer. Discard the buffer from the collection tube. Repeat this process for 3-4 times.

  5. Centrifuge at 1000 x g for 2 minutes in a swinging bucket centrifuge to remove the packing buffer. Then discard the buffer. Refer to the 'Centrifugation Notes' section below for instructions.

  6. Place the column into a clean collecting tube (1.5 mL, not provided). Then, take the antibody-Buccutite™ MTA solution from step 3 of the "Run Antibody-Buccutite™ MTA Reaction" section and load it carefully and directly into the center of the column.

  7. After loading the sample, add 40 μL of 1X PBS (pH 7.2-7.4), centrifuge the column for 2 minutes at 1,000 x g, and collect the solution that contains the desired antibody-Buccutite™ MTA solution.

Run Antibody-APC Conjugation Reaction
  1. Warm up a vial of Buccutite™ FOL-Activated APC (Component A) to room temperature.

    Note: Each vial of Buccutite™ FOL-Activated APC contains an optimized amount of dye to label 1 mg of IgG (MW ~150 kDa) at 2 mg/mL in PBS, the kit can also be used to label other proteins (>10 kDa).

  2. Make a Buccutite™ FOL-Activated APC solution by adding 130 µL of ddH2O into the vial of Buccutite™ FOL-Activated APC (Component A), and mix well by pipetting or vortexing.

  3. Add the purified Antibody-Buccutite™ MTA solution directly into the vial of Buccutite™ FOL-Activated APC solution. Rotate the mixture for 1-2 hours at room temperature.

  4. The antibody-APC conjugate is now ready for immediate use or can be stored at 4°C.

Purification with Size Exclusion Chromatography Recommended
  1. For optimal performance, it is recommended to purify the antibody-APC conjugate using size exclusion chromatography (SEC). The following SEC columns are suitable for this purpose: Superdex 200 Increase 100/300 GL (Cytiva) and ENrich™ SEC 650 10 x 300 Column (Bio-Rad).

Spectrum


Open in Advanced Spectrum Viewer
spectrum

Spectral properties

Correction Factor (280 nm)0.195
Extinction coefficient (cm -1 M -1)730000
Excitation (nm)651
Emission (nm)660

Images


References


View all 50 references: Citation Explorer
3-Polythiophene Acetic Acid Nanosphere Anchored Few-Layer Graphene Nanocomposites for Label-Free Electrochemical Immunosensing of Liver Cancer Biomarker.
Authors: Gangopadhyay, Bhuman and Roy, Aindrila and Paul, Debanjan and Panda, Subrata and Das, Beauty and Karmakar, Srikanta and Dutta, Koushik and Chattopadhyay, Sanatan and Chattopadhyay, Dipankar
Journal: ACS applied bio materials (2024)
Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.
Authors: Cui, Yingshu and Xu, Yuanyuan and Li, Yi and Sun, Yuanyuan and Hu, Jia and Jia, Jia and Li, Xiaosong
Journal: Technology in cancer research & treatment (2023): 15330338221145992
Synergistic Approach of Antibody-Photosensitizer Conjugate Independent of KRAS-Mutation and Its Downstream Blockade Pathway in Colorectal Cancer.
Authors: Ahn, Minji and Lee, Taebum and Kim, Kyoung Sub and Lee, Sanghee and Na, Kun
Journal: Advanced healthcare materials (2023): e2302374
[Bioactive compounds anthocyanins as a factor in the nutritional recovery of the body's adaptive potential after intense physical activity in the experiment: assessment of immunological and hematological indicators of adaptation].
Authors: Trushina, E N and Mustafina, O K and Aksenov, I V and Krasutsky, A G and Nikityuk, D B and Tutelyan, V A
Journal: Voprosy pitaniia (2023): 6-15
Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
Authors: Zaninelli, Silvia and Meli, Cristian and Borleri, Gianmaria and Quaroni, Michele and Pavoni, Chiara and Gaipa, Giuseppe and Biondi, Andrea and Introna, Martino and Golay, Josée and Rambaldi, Alessandro and Rambaldi, Benedetta
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology (2023)
An Analysis of Linker-Dependent Effects on the APC Activation and In Vivo Immunogenicity of an R848-Conjugated Influenza Vaccine.
Authors: Crofts, Kali F and Page, Courtney L and Swedik, Stephanie M and Holbrook, Beth C and Meyers, Allison K and Zhu, Xuewei and Parsonage, Derek and Westcott, Marlena M and Alexander-Miller, Martha A
Journal: Vaccines (2023)
The association of decreased HLA-G+ immune cell frequencies with critical COVID-19 patients.
Authors: Ramzannezhad, Somayeh and Tarighi, Mona and Mohammadnia-Afrouzi, Mousa and Aghapour, Soudabeh and Bagherzadeh, Mojgan and Ahmadnia, Zahra and Hosseini, Akramossadat and Javanian, Mostafa and Ghorbani, Housein and Shahbazi, Mehdi
Journal: Microbial pathogenesis (2022): 105550
Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.
Authors: Li, Wen-Hao and Su, Jing-Yun and Li, Yan-Mei
Journal: Accounts of chemical research (2022): 2660-2671
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Authors: Okada, Ryuhei and Kato, Takuya and Furusawa, Aki and Inagaki, Fuyuki and Wakiyama, Hiroaki and Fujimura, Daiki and Okuyama, Shuhei and Furumoto, Hideyuki and Fukushima, Hiroshi and Choyke, Peter L and Kobayashi, Hisataka
Journal: Cancer immunology, immunotherapy : CII (2022): 1877-1887
Comparison of the Effectiveness of IgG Antibody versus F(ab')2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy.
Authors: Kato, Takuya and Okada, Ryuhei and Furusawa, Aki and Wakiyama, Hiroaki and Furumoto, Hideyuki and Fukushima, Hiroshi and Okuyama, Shuhei and Choyke, Peter L and Kobayashi, Hisataka
Journal: Molecular pharmaceutics (2022): 3600-3611